Paul Stuka Biography and Net Worth

Director of InspireMD


Mr. Stuka was named to the Board of Directors in August of 2011 and serves as Chairman of the Board of Directors. Mr. Stuka is a Managing Member of Osiris Partners and a 30-year investment industry veteran. Prior to forming Osiris Partners, he was a Managing Director of Longwood Partners, managing small cap institutional accounts. In 1995, he joined State Street Research and Management as manager of its Market Neutral and Mid Cap Growth Funds. From 1986 to 1994, he served as the general partner of Stuka Associates, where he managed a U.S.-based investment partnership. Mr. Stuka began his career in 1980 as an analyst at Fidelity Management and Research. As an analyst, he followed a wide array of industries including healthcare, energy, transportation, and lodging & gaming. Early in his career he became the assistant portfolio manager for three Fidelity Funds, including the Select Healthcare Fund, which was recognized as the top performing fund in the U.S. for the five-year period ending December 31, 1985. In 1984 he became the original manager of the Fidelity OTC Fund, which was the second-best performing U.S. mutual fund for 1985, appreciating 69%. At the time of his departure in June, 1986, the Fund had appreciated over 115% in 18 months and assets approached $1 billion. During his career, Mr. Stuka has been featured in articles in The Wall Street Journal, Barron’s, The New York Times, and BusinessWeek.

What is Paul Stuka's net worth?

The estimated net worth of Paul Stuka is at least $462.17 thousand as of May 27th, 2026. Stuka owns 667,871 shares of InspireMD stock worth more than $462,167 as of September 29th. This net worth approximation does not reflect any other assets that Stuka may own. Learn More about Paul Stuka's net worth.

How do I contact Paul Stuka?

The corporate mailing address for Stuka and other InspireMD executives is 6303 Waterford District Drive, Suite 215, Miami, FL, 33126. InspireMD can also be reached via phone at 9728887766804 and via email at [email protected]. Learn More on Paul Stuka's contact information.

Has Paul Stuka been buying or selling shares of InspireMD?

Paul Stuka has not been actively trading shares of InspireMD during the last ninety days. Most recently, on Wednesday, May 27th, Paul Stuka bought 20,000 shares of InspireMD stock. The stock was acquired at an average cost of $0.88 per share, with a total value of $17,600.00. Following the completion of the transaction, the director now directly owns 667,871 shares of the company's stock, valued at $587,726.48. Learn More on Paul Stuka's trading history.

Who are InspireMD's active insiders?

InspireMD's insider roster includes Gary Roubin (Director), Paul Stuka (Director), and Scott Ward (Director). Learn More on InspireMD's active insiders.

Are insiders buying or selling shares of InspireMD?

In the last year, InspireMD insiders bought shares 9 times. They purchased a total of 303,771 shares worth more than $348,697.40. In the last year, insiders at the sold shares 12 times. They sold a total of 86,913 shares worth more than $126,870.28. The most recent insider tranaction occured on May, 27th when Director Paul Stuka bought 20,000 shares worth more than $17,600.00. Insiders at InspireMD own 25.0% of the company. Learn More about insider trades at InspireMD.

Information on this page was last updated on 5/27/2026.

Paul Stuka Insider Trading History at InspireMD

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/27/2026Buy20,000$0.88$17,600.00667,871View SEC Filing Icon  
5/11/2026Buy10,000$1.19$11,900.00632,871View SEC Filing Icon  
5/8/2026Buy65,626$1.16$76,126.16622,871View SEC Filing Icon  
5/7/2026Buy6,378$1.15$7,334.70531,599View SEC Filing Icon  
5/6/2026Buy1,517$1.12$1,699.04525,221View SEC Filing Icon  
7/30/2025Buy20,661$2.42$49,999.62444,195View SEC Filing Icon  
5/12/2023Buy175,000$1.63$285,250.00248,534View SEC Filing Icon  
See Full Table

Paul Stuka Buying and Selling Activity at InspireMD

This chart shows Paul Stuka's buying and selling at InspireMD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

InspireMD Company Overview

InspireMD logo
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Read More

Today's Range

Now: $0.69
Low: $0.68
High: $0.70

50 Day Range

MA: $0.79
Low: $0.65
High: $0.98

2 Week Range

Now: $0.69
Low: $0.63
High: $2.57

Volume

1,325 shs

Average Volume

140,490 shs

Market Capitalization

$32.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83